Jinling Pharmaceutical Company Company Description
Jinling Pharmaceutical Company Limited manufactures and sells pharmaceutical products and medical devices in China.
The company provides Mailuoning injection/oral solutions for the treatment of thromboangiitis obliterans, arteriosclerosis obliterans, cerebral thrombosis and sequelae, polyarteritis, acute arterial embolism of extremities, diabetic gangrene, intravenous thrombus, thrombophlebitis, etc.; ferrous succinate tablets for the prevention and treatment of iron deficiency anemia; lentinan injection for the treatment of malignant tumors; and absorbable gelatin sponges for the treatment of wound hemostasis.
It also offers medical and health care services. Jinling Pharmaceutical Company Limited was founded in 1998 and is headquartered in Nanjing, China.
Country | China |
Founded | 1998 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 5,789 |
CEO | Hai Chen |
Contact Details
Address: Jinling Pharmaceutical Building Nanjing, 210009 China | |
Phone | 86 25 8311 8511 |
Website | jlyy1999.com |
Stock Details
Ticker Symbol | 000919 |
Exchange | Shenzhen Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CNY |
ISIN Number | CNE0000010W5 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Hai Chen | President and Director |
Yang Wang | Vice President, Chief Accountant, Secretary and Non-Independent Director |
Quan Li | Chief Economist |
Mingyi Jia | Chief Engineer |
Jian Wang | Executive Vice President and Non-Independent Director |
Jian Li | Vice President |
Xinning Zhu | Assistant to President |
Zhenxin Xi | General Manager Assistant |
Xin Liu | Assistant to the President |
Mingyi Jia | Chief Engineer |